Form 4 for TECH Bio-Techne
Accepted 2025-07-17 00:00:00 ET · period of report 2025-07-15 · accession 0001062993-25-012967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-17 | 2025-07-15 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $51.42 | -32.9K | 42.2K | -44% | -$1.69M |
| D | 2025-07-17 | 2025-07-15 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $44.33 | +36.1K | 75.1K | +93% | +$1.60M |
| D | 2025-07-17 | 2025-07-15 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -36.1K | 48.2K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-15 | F | D | 32,933 | $51.42 | 42,203 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-15 | M | A | 36,132 | $44.33 | 75,136 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-07-15 | M | D | 36,132 | $0.00 | 48,176 | D | $44.33 · — to 2025-08-08 | 36,132 Common Stock | (F1) Fully exercisable. |